Clinical Trial Update: Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating cladribine with BEAC pretreatment in peripheral T-cell lymphoma; efficacy and safety results not yet available in the provided…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• BEAC regimen (BEAC)
• Cladribine (cladribine)

Snippet

Sponsor: Ruijin Hospital | Conditions: Peripheral T-cell Lymphoma | Phase 3 | Status: UNKNOWN